Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 440
405 30 Göteborg
0313421000
Fax: +46 31846113

Visiting Address: Medicinaregatan 3, plan 5 , 405 30 Göteborg

Latest publications

Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Tomas Mellberg, Jon Krabbe, Maria Buzon, Ulrika Noborg, Magnus Lindh et al.
International Journal of Virology and AIDS, Journal article 2017
Journal article

Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers.
Rosan A Van Zoest, Jonathan Underwood, Davide De Francesco, Caroline A Sabin, James H Cole et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
A. Haggblom, M. Santacatterina, U. Neogi, Magnus Gisslén, B. Hejdeman et al.
Plos One, Journal article 2017
Journal article

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden
U. Neogi, A. B. Siddik, P. Kalaghatgi, Magnus Gisslén, G. Bratt et al.
Scientific Reports, Journal article 2017
Journal article

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Elham Rahimy, Fang-Yong Li, Lars Hagberg, Dietmar Fuchs, Kevin Robertson et al.
The Journal of infectious diseases, Journal article 2017
Journal article

Showing 61 - 70 of 148

2011

Rebound of residual plasma viremia after initial decrease following addition of intravenous immunoglobulin to effective antiretroviral treatment of HIV
Tomas Mellberg, Veronica D Gonzalez, Annica Lindkvist, Arvid Edén, Anders Sönnerborg et al.
AIDS Research and Therapy, Journal article 2011
Journal article

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2010.
Lars Navér, Jan Albert, Erik Belfrage, Leo Flamholc, Magnus Gisslén et al.
Scandinavian journal of infectious diseases, Journal article 2011
Journal article

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.
Dinko Rekić, Oskar Clewe, Daniel Röshammar, Leo Flamholc, Anders Sönnerborg et al.
The AAPS journal, Journal article 2011
Journal article

HIV-1 infection and cognitive impairment in the cART-era: a review.
Judith Schouten, Paola Cinque, Magnus Gisslén, Peter Reiss, Peter Portegies
AIDS, Journal article 2011
Journal article

2010

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.
Arvid Edén, Dietmar Fuchs, Lars Hagberg, Staffan Nilsson, Serena Spudich et al.
The Journal of infectious diseases, Journal article 2010
Journal article

Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients.
Arvid Edén, Lars-Magnus Andersson, Orjan Andersson, Leo Flamholc, Filip Josephson et al.
AIDS research and human retroviruses, Journal article 2010
Journal article

Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy.
Aylin Yilmaz, Chris Verhofstede, Antonio Dʼavolio, Victoria Watson, Lars Hagberg et al.
Journal of acquired immune deficiency syndromes (1999), Journal article 2010
Journal article

Medical Resource Utilization and Cost of HIV-Related Care in the Highly Active Antiretroviral Therapy Era at a University Clinic in Sweden.
Ola Ghatnekar, Catharina Hjortsberg, Magnus Gisslén, Stefan Lindbäck, Mickael Löthgren
PharmacoEconomics, Journal article 2010
Journal article

Showing 61 - 70 of 148

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?